Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 79

1.
2.

Synthesis of nucleotide sugars and α-galacto-oligosaccharides by recombinant Escherichia coli cells with trehalose substrate.

Ryu SI, Lee SB.

Enzyme Microb Technol. 2013 Oct 10;53(5):359-63. doi: 10.1016/j.enzmictec.2013.07.009. Epub 2013 Aug 13.

PMID:
24034436
3.

Characterization of UDP-glucose 4-epimerase from Pyrococcus horikoshii: regeneration of UDP to produce UDP-galactose using two-enzyme system with trehalose.

Chung SK, Ryu SI, Lee SB.

Bioresour Technol. 2012 Apr;110:423-9. doi: 10.1016/j.biortech.2012.01.046. Epub 2012 Jan 28.

PMID:
22342090
4.

Structural insights on the new mechanism of trehalose synthesis by trehalose synthase TreT from Pyrococcus horikoshii.

Woo EJ, Ryu SI, Song HN, Jung TY, Yeon SM, Lee HA, Park BC, Park KH, Lee SB.

J Mol Biol. 2010 Nov 26;404(2):247-59. doi: 10.1016/j.jmb.2010.09.056. Epub 2010 Oct 1.

PMID:
20888836
6.

Inhibition of anti-Gal IgG binding to porcine endothelial cells by synthetic oligosaccharides.

Galili U, Matta KL.

Transplantation. 1996 Jul 27;62(2):256-62.

PMID:
8755825
7.

Bioengineered 2'-fucosyllactose and 3-fucosyllactose inhibit the adhesion of Pseudomonas aeruginosa and enteric pathogens to human intestinal and respiratory cell lines.

Weichert S, Jennewein S, Hüfner E, Weiss C, Borkowski J, Putze J, Schroten H.

Nutr Res. 2013 Oct;33(10):831-8. doi: 10.1016/j.nutres.2013.07.009. Epub 2013 Aug 13.

PMID:
24074741
9.

Enhanced production of alpha-galactosyl epitopes by metabolically engineered Pichia pastoris.

Shao J, Hayashi T, Wang PG.

Appl Environ Microbiol. 2003 Sep;69(9):5238-42.

10.

Evaluation of enhanced hygroscopicity, bifidogenicity, and anticariogenicity of enzymatically synthesized beta-galactosyl-trehalose oligosaccharides.

Ryu SI, Kim BG, Park MS, Lee YB, Lee SB.

J Agric Food Chem. 2007 May 16;55(10):4184-8. Epub 2007 Apr 13.

PMID:
17429983
11.

A novel trehalose-synthesizing glycosyltransferase from Pyrococcus horikoshii: molecular cloning and characterization.

Ryu SI, Park CS, Cha J, Woo EJ, Lee SB.

Biochem Biophys Res Commun. 2005 Apr 8;329(2):429-36.

PMID:
15737605
12.

Anti-alpha-galactosyl immunoglobulin A (IgA), IgG, and IgM in human secretions.

Hamadeh RM, Galili U, Zhou P, Griffiss JM.

Clin Diagn Lab Immunol. 1995 Mar;2(2):125-31.

13.
14.

Large-scale production of UDP-galactose and globotriose by coupling metabolically engineered bacteria.

Koizumi S, Endo T, Tabata K, Ozaki A.

Nat Biotechnol. 1998 Sep;16(9):847-50.

PMID:
9743118
16.

Protection of pig kidney (PK15) cells from the cytotoxic effect of anti-pig antibodies by alpha-galactosyl oligosaccharides.

Neethling FA, Koren E, Ye Y, Richards SV, Kujundzic M, Oriol R, Cooper DK.

Transplantation. 1994 Mar 27;57(6):959-63.

PMID:
8154046
17.

Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells.

Galili U, Shohet SB, Kobrin E, Stults CL, Macher BA.

J Biol Chem. 1988 Nov 25;263(33):17755-62.

18.

Increased anti-Gal activity in diabetic patients transplanted with fetal porcine islet cell clusters.

Galili U, Tibell A, Samuelsson B, Rydberg L, Groth CG.

Transplantation. 1995 Jun 15;59(11):1549-56.

PMID:
7539957
19.

Metabolic engineering of Agrobacterium sp. strain ATCC 31749 for production of an alpha-Gal epitope.

Ruffing AM, Chen RR.

Microb Cell Fact. 2010 Jan 12;9:1. doi: 10.1186/1475-2859-9-1.

Supplemental Content

Support Center